A Study to Learn How Different Levels of Decreased Liver Function Influence Blood Levels of Elinzanetant Compared to Normal Liver Function in Male and Female Participants

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

June 1, 2021

Primary Completion Date

March 15, 2022

Study Completion Date

March 15, 2022

Conditions

Vasomotor Symptoms as a Sex Hormone-dependent Disorder in Women and Men

Interventions

DRUG

BAY3427080

Orally administered, single dose on Day 1 and single does once daily on Day 3 to 8

Trial Locations (2)

CRS Clinical-Research-Services Kiel GmbH, Kiel

APEX GmbH, München